$4.87
-0.28 (-5.44%)
Open$5.07
Previous Close$5.15
Day High$5.11
Day Low$4.86
52W High$19.35
52W Low$3.76
Volume—
Avg Volume63.3K
Market Cap41.77M
P/E Ratio—
EPS$-4.04
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+72.9% upside
Current
$4.87
$4.87
Target
$8.42
$8.42
$5.85
$8.42 avg
$9.99
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.66M | 19.11M | 19.03M |
| Net Income | -1,423,753 | -1,667,488 | -1,447,772 |
| Profit Margin | -6.6% | -8.7% | -7.6% |
| EBITDA | -1,912,051 | -1,729,452 | -1,852,839 |
| Free Cash Flow | -992,506 | -967,985 | -917,697 |
| Rev Growth | +8.7% | -4.8% | +0.2% |
| Debt/Equity | 0.16 | 0.13 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |